Global Patient Blood Management Market to Reach $23.6 Billion by 2030
The global market for Patient Blood Management estimated at US$13.3 Billion in the year 2022, is projected to reach a revised size of US$23.6 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 7.6% CAGR and reach US$10.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents & Kits segment is readjusted to a revised 8.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 12.2% CAGR
The Patient Blood Management market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.Select Competitors (Total 42 Featured) -
- Abbott Laboratories
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Biomérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche LTD.
- Fresenius Se & Co. KGaA
- Grifols, S.A.
- Haemonetics Corporation
- Immucor, Inc.
- Kaneka Corporation
- Livanova PLC
- Macopharma
- Terumo Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Biomérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche LTD.
- Fresenius Se & Co. KGaA
- Grifols, S.A.
- Haemonetics Corporation
- Immucor, Inc.
- Kaneka Corporation
- Livanova PLC
- Macopharma
- Terumo Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 13.3 Billion |
Forecasted Market Value ( USD | $ 23.6 Billion |
Compound Annual Growth Rate | 7.4% |
Regions Covered | Global |